Organization
Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet
1 abstract
Abstract
ADDITION OF INFLIXIMAB COMPARED WITH ADDITION OF SULFASALAZINE AND HYDROXYCHLOROQUINE TO METHOTREXATE IN EARLY RHEUMATOID ARTHRITIS: 2-YEAR QUALITY OF LIFE RESULTS OF THE RANDOMISED, CONTROLLED SWEFOT TRIAL Org: Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund, Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet, Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, Deptartment of Biochemistry, Hanoi Medical University, Hanoi, Viet Nam,